In vitro detoxification of cyclosarin (GF) by modified cyclodextrins

Toxicology Letters

Volumn 200, Issue 1-2, 2011, Pages 53-58

  Müller, Susanne ^a   Koller, Marianne ^a   Le Provost, Romain ^b,c   Lafont, Olivier ^c   Estour, François ^b,c   Wille, Timo ^a   Thiermann, Horst ^a   Worek, Franz ^a   Reiter, Georg ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

^b Normandie Université   (France)

^c UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cyclodextrin; Cyclosarin; Detoxification; Organophosphorus compound; Toxicokinetics

Indexed keywords

2 IODOSOBENZOIC ACID; 2 O (3 CARBOXY 4 IODOSOBENZYL) BETA CYCLODEXTRIN; 2 O BENZYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; CYCLOSARIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); DETOXIFICATION; DRUG SCREENING; IN VITRO STUDY; IN VIVO STUDY; IONIZATION; MASS SPECTROMETRY; PRIORITY JOURNAL; TOXICOKINETICS;

ANTIDOTES; BETA-CYCLODEXTRINS; CHOLINESTERASE INHIBITORS; CYCLODEXTRINS; HYDROLYSIS; KINETICS; ORGANOPHOSPHORUS COMPOUNDS;

EID: 78650171741     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.10.014     Document Type: Article

References (51)

1. Bertolote J.M., Fleischmann A., Eddleston M., Gunnell D. Deaths from pesticide poisoning: a global response. Br. J. Psychiatr. 2006, 189:201-203.
2. Bikadi Z., Kurdi R., Balogh S., Szeman J., Hazai E. Aggregation of cyclodextrins as an important factor to determine their complexation behavior. Chem. Biodivers. 2006, 3(11):1266-1278.
3. Cramer F., Saenger W., Spatz H.C. Inclusion compounds. XIX. The formation of inclusion compounds of α-cyclodextrin in aqueous solutions. Thermodynamics and kinetics. J. Am. Chem. Soc. 1967, 89(1):14-20.
4. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994, 14(5):317-331.
5. Desiré B., Saint-André S. Interaction of soman with β-cyclodextrin. Fund. Appl. Toxicol. 1986, 7(4):646-657.
6. Desiré B., Saint-André S. Inactivation of sarin and soman by cyclodextrins in vitro. Experientia 1987, 43(4):395-397.
7. 2+-catalyzed methanolysis of phosphate triesters: a process for catalytic degradation of the organophosphorus pesticides paraoxon and fenitrothion. Inorg. Chem. 2004, 43(21):6752-6761.
8. Doctor B.P., Blick D.W., Caranto G., Castro C.A., Gentry M.K., Larrison R., Maxwell D.M., Murphy M.R., Schutz M., Waibel K., Wolfe A.D. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity. Chem. Biol. Interact. 1993, 87(1-3):285-293.
9. Eddleston M., Worek F., Eyer P., Thiermann H., Von Meyer L., Jeganathan K., Sheriff M.H.R., Dawson A.H., Buckley N.A. Poisoning with the S-alkyl organophosphorus insecticides profenofos and prothiofos. Q. J. Med. 2009, 102(11):785-792.
10. Eddleston M., Buckley N.A., Eyer P., Dawson A.H. Management of acute organophosphorus pesticide poisoning. Lancet 2008, 371(9612):597-607.
11. Epstein J., Michel H.O., Rosenblatt D.H., Plapinger R.E., Stephani R.A., Cook E. Reactions of isopropyl methylphosphonofluoridate with substituted phenols. II. J. Am. Chem. Soc. 1964, 86(22):4959-4963.
12. Epstein J., Plapinger R.E., Michel H.O., Cable J.R., Stephani R.A., Hester R.J., Billington C., List G.R. Reactions of isopropyl methylphosphonofluoridate with substituted phenols. I. J. Am. Chem. Soc. 1964, 86(15):3075-3084.
13. Eyer F., Meischner V., Kiderlen D., Thiermann H., Worek F., Haberkorn M., Felgenhauer N., Zilker T., Eyer P. Human parathion poisoning. A toxicokinetic analysis. The role of oximes in the management of organophosphorus pesticide poisoning. Toxic. Rev. 2003, 22(3):143-163.
14. Eyer F., Worek F., Eyer P., Felgenhauer N., Haberkorn M., Zilker T., Thiermann H. Human parathion poisoning. A toxicokinetic analysis. The role of oximes in the management of organophosphorus pesticide poisoning. Clin. Toxicol. 2009, 47(8):798-806.
15. Eyer P., Kiderlen D., Meischner V., Szinicz L., Thiermann H., Worek F., Eyer F., Felgenhauer N., Pfab R., Zilker T., Eddleston M., Senarathna L., Sheriff R., Buckley N. The current status of oximes in the treatment of OP poisoning-comparing two regimes. Clin. Toxicol. 2003, 41(4):441-443.
16. Eyer P., Thiermann H., Worek F., Szinicz L., Eyer F., Zilker T. The role of atropine and oximes in the treatment of organophosphorus insecticide poisoning. Clin. Toxicol. 2005, 43(5):447-448.
17. Gunnell D., Eddleston M. Suicide by intentional ingestion of pesticides: a continuing tragedy in developing countries. Int. J. Epidemiol. 2003, 32(6):902-909.
18. Hammond P.S., Forster J.S., Lieske C.N., Durst H.D. Hydrolysis of toxic organophosphorus compounds by o-iodosobenzoic acid and its derivatives. J. Am. Chem. Soc. 1989, 111(20):7860-7866.
19. Hennrich N., Cramer F. Inclusion compounds. XVIII. The catalysis of the fission of pyrophosphates by cyclodextrin. A model reaction for the mechanism of enzymes. J. Am. Chem. Soc. 1965, 87(5):1121-1126.
20. Holmstedt B. Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol. Rev. 1959, 11(3):567-688.
21. Hoskin F.C.G., Steeves D.M., Walker J.E. Substituted cyclodextrin as a model for a squid enzyme that hydrolyzes the nerve gas soman. Biol. Bull. 1999, 197(2):284-285.
22. Lenz D.E., Yeung D., Smith J.R., Sweeney R.E., Lumley L.A., Cerasoli D.M. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicol. 2007, 233(1-3):31-39.
23. Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 1993, 58(1):51-66.
24. Masson P., Nachon F., Broomfield C.A., Lenz D.E., Verdier L., Schopfer L.M., Lockridge O. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem. Biol. Interact. 2008, 175(1-3):273-280.
25. Masurier N., Estour F., Froment M.T., Lefevre B., Debouzy J.C., Brasme B., Masson P., Lafont O. Synthesis of 2-substituted β-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon. Eur. J. Med. Chem. 2005, 40(7):615-623.
26. Masurier N., Estour F., Lefèvre B., Brasme B., Masson P., Lafont O. Improved access to 2-O-monobenzyl ethers of β-cyclodextrin as precursors of catalysts for organophosphoryl esters hydrolysis. Carbohydr. Res. 2006, 341(7):935-940.
27. Mirams R.E., Smith S.J., Hadler K.S., Ollis D.L., Schenk G., Gahan L.R. Cadmium(II) complexes of the glycerophosphodiester-degrading enzyme GpdQ and a biomimetic N,O ligand. J. Biol. Inorg. Chem. 2008, 13(7):1065-1072.
28. Nagao M., Takatori T., Matsuda Y., Nakajima M., Niijima H., Iwase H., Iwadate K., Amano T. Detection of sarin hydrolysis products from sarin-like organophosphorus agent-exposed human erythrocytes. J. Chromatogr. B 1997, 701(1):9-17.
29. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth. Analg. 2007, 104(3):575-581.
30. Nakajima T., Sato S., Morita H., Yanagisawa N. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup. Environ. Med. 1997, 54(10):697-701.
31. Reiter G., Koller M., Thiermann H., Dorandeu F., Mikler J., Worek F. Development and application of procedures for the highly sensitive quantification of cyclosarin enantiomers in hemolysed swine blood samples. J. Chromatogr. B 2007, 859(1):9-15.
32. Reiter G., Mikler J., Hill I., Weatherby K., Thiermann H., Worek F. Chromatographic resolution, characterisation and quantification of VX enantiomers in hemolysed swine blood samples. J. Chrom. B. 2008, 873(1):86-94.
33. Samuel D., Silver B.L. The elucidation of the reaction of benzohydroxamic acid with benzenesulfonyl chloride and with diisopropyl phosphofluoridate using oxygen-18 as tracer. J. Am. Chem. Soc. 1963, 85(8):1197-1198.
34. Shih T.M., Rowland T.C., McDonough J.H. Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. J. Pharmacol. Exp. Ther. 2007, 320(1):154-161.
35. Sogorb M.A., Carrera V., Vilanova E. Hydrolysis of carbaryl by human serum albumin. Arch. Toxicol. 2004, 78(11):629-634.
36. Stolberg M.A., Mosher W.A. Rates of reaction of vicinally substituted hydroxamic acids with isopropyl methylphosphonofluoridate (Sarin). J. Am. Chem. Soc. 1957, 79(10):2618-2620.
37. Suzuki T., Morita H., Ono K., Maekama K., Nagai R., Yazaki Y., Nozaki H., Aikawa N., Shinozawa Y., Hori S., Fujishima S., Takuma K., Sagoh M. Sarin poisoning in Tokio subway. Lancet 1995, 345(8955):980-981.
38. Szejtli J. The cyclodextrins and their applications in biotechnology. Carbohydr. Polym. 1990, 12(4):375-392.
39. Tafesse F. Hydrolysis of nerve agent simulants by synergistic effects of tetraminecobalt(III) and microemulsions. Inorg. Chim. Act. 1998, 269(2):287-291.
40. Takahashi K. Organic reactions mediated by cyclodextrins. Chem. Rev. 1998, 98(5):2013-2034.
41. Thiermann H., Seeger T., Gonder S., Herkert N., Antkowiak B., Zilker T., Eyer F., Worek F. Assessment of neuromuscular dysfunction during poisoning by organophosphorus compounds. Chem. Biol. Interact. 2010, 187(1-3):265-269.
42. van der Schans M.J., Lander B.J., van der Wiel H., Langenberg J.P., Benschop H.P. Toxicokinetics of the nerve agent (±)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 2003, 191(1):48-62.
43. Van Hooidonk C. Model studies for enzyme inhibition. Part V. Recueil 1972, 91:1103-1109.
44. Van Hooidonk C., Breebaart-Hansen J.C. Stereospecific reaction of isopropyl methyl-methosphonofluoridate (Sarin) with α-cyclodextrin. Recueil 1970, 89:289-299.
45. Van Hooidonk C., Breebaart-Hansen J.C. Model studies for enzyme inhibition. Part IV. Recueil 1972, 91:958-964.
46. Van Hooidonk C., Groos C.C. Model studies for enzyme Inhibition, Part II. Recueil 1970, 89:845-856.
47. Wille T., Tenberken O., Reiter G., Müller S., Le Provost R., Lafont O., Estour F., Thiermann H., Worek F. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay. Toxicology 2009, 265(3):96-100.
48. Worek F., Aurbek N., Koller M., Becker C., Eyer P., Thiermann H. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates. Biochem. Pharmacol. 2007, 73(11):1807-1817.
49. Worek F., Thiermann H., Sziniz L., Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol. 2004, 68(11):2237-2248.
50. Yeung D.T., Lenz D.E., Cerasoli D.M. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates. FEBS J. 2005, 272(9):2225-2230.
51. Zhang A., Liu W. Inclusion effect of alpha-cyclodextrin on chemical degradation of malathion in water. Arch. Environ. Contam. Toxicol. 2008, 54(3):355-362.